COMPACT SEQUENCING

Cube Dx was founded in 2015 and is located in St. Valentin (Austria). The company focuses on the development, production and distribution of multiplex tests for in-vitro diagnostics in clinical routine. Multiplex diagnostics allow for parallel identification of a variety of significant parameters (bacteria, fungi, resistance markers etc.) in a single test, requiring only a minimal amount of sample material... Cube Dx' entirely new multiplex technology - the hybcell - is the world's first cylindrical microarray and delivers speedy and reliable results with minimal effort. The hyborg - a completely automated device - processes the samples fully independently and without any intervention by the user. The Cube Dx assay is based on compact sequencing and is designed to address especially those complex diagnostic challenges where fast answers are essential... Fight infections! Diagnose early. Over 100 microbial species and resistance genes in just 3 hours directly from whole blood - Cube..

Registration numbers: 435233z (W)

VAT numbers: ATU 69753849

Primary location: Sankt Valentin